by in
Entry Author Date Location
At U-M, 40 Years Of Gaucher Research Rewarded With FDA Approval 09/11/14 Detroit
East Coast Biotech Roundup: NJ Blues, Genzyme, Amicus, Biogen & More 08/25/14 Boston
Amicus Counts on “Chaperone” Tech to Enhance Rare Disease Treatments 01/11/12 New York
Shire Finds Big Value in Rare Diseases, and a Strong Growth Path for its Boston Unit 05/12/11 New York
Edimer, Third Rock’s Bet on Rare Diseases, Aims to Begin First Human Tests 03/15/11 Boston
Genzyme Rival Seeks European Approval 11/24/09 Boston
Genzyme Says Supplies, Sales of Two Enzyme Drugs Will Be Even Lower Than Previously Predicted 09/23/09 Boston
Genzyme Oral Pill for Gaucher’s Succeeds in Trial, Aims to Extend Key Revenue Stream 02/20/09 Boston
Boston Biotechs Seek Scarce Funds Amid Market Famine at Annual Pitch Event 12/04/08 Boston
Page 1 of 1